发明名称 USE OF A THERAPEUTICALLY EFFECTIVE AMOUNT OF AN AGENT IN THE PREPARATION OF MEDICAMENTS FOR TREATING A TH2-MEDIATED DISORDER, PROMOTING A TH1 IMMUNE RESPONSE OR TREATING EOSINOPHILIA
摘要 <p>The invention relates to methods of modulating immune responses in a subject such as by administering to the subject agents which modulate tim-1, tim-2 or tim-4 activity, or which modulate the physical interaction between tim-1 and tim-4 or between tim-2 and a tim-2 ligand. Immune responses include, but are not limited to, autoimmune disorders, transplantation tolerance, and Th1 and Th2-mediated responses and disorders. The invention also relates to novel assays for identifying agents which modulate the physical interaction between tim-1 and tim-4. In addition, the invention relates to novel soluble tim-4 polypeptides and to nucleic acids which encode them.</p>
申请公布号 IL178002(A) 申请公布日期 2011.12.29
申请号 IL20060178002 申请日期 2006.09.11
申请人 THE BRIGHAM AND WOMEN'S HOSPITAL, INC.;BETH ISRAEL DEACONESS MEDICAL CENTER 发明人
分类号 A61K38/17;A61K39/395;A61K48/00;C07K14/705;C07K16/28;C12N15/11;G01N33/576;G01N33/68 主分类号 A61K38/17
代理机构 代理人
主权项
地址
您可能感兴趣的专利